Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) has crafted a new addition for its Glacial Gold line that it says will give users a perfect start to their day without the risk of becoming intoxicated.
On Wednesday, the company announced the debut of its Rise & Shine CBD Drops.
Nextleaf also revealed that it had successfully completed its first bulk sale of THC-free CBD ingredients to an anonymous multinational partner.
Read more: Nextleaf adds to its Glacial Gold catalogue
Read more: Tilray receives approval for CBD oral solution in Australia and New Zealand
Nextleaf is a company that possesses a Health Canada Research License enabling it to develop cannabinoid-based formulations and delivery technology. The organization also says it was the first public company to receive a U.S. patent for industrial-scale extraction and purification of cannabinoids.
The Canadian manufacturer of cannabis vapes and oils states that its THC-free CBD will be an alternative to CBD isolate for those seeking a more holistic pot product.
Nextleaf was also quite pleased with the Science Advisory Committee report from Health Canada in July where the committee unanimously agreed that CBD was safe and tolerable for short-term use at 20 milligrams to 200 milligrams per day.
“After validating the technology to produce THC-Free CBD, we are pleased to commercialize the new ingredient under the Glacial Gold brand,” said Kevin Keagan, Chief Financial Officer at Nextleaf.
“With Health Canada releasing its Science Advisory Committee Report on CBD in late July, we are on the brink of a major catalyst for the CBD industry, and as a Canadian leader in CBD innovation and production we welcome the potential, future changes in regulations.”